» Articles » PMID: 10091831

Is the Development of Myocardial Tolerance to Repeated Ischemia in Humans Due to Preconditioning or to Collateral Recruitment?

Overview
Date 1999 Mar 26
PMID 10091831
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The purpose of this study in patients with quantitatively determined, poorly developed coronary collaterals was to assess the contribution of ischemic as well as adenosine-induced preconditioning and of collateral recruitment to the development of tolerance against repetitive myocardial ischemia.

Background: The development of myocardial tolerance to repeated ischemia is nowadays interpreted to be due to biochemical adaptation (i.e., ischemic preconditioning).

Methods: In 30 patients undergoing percutaneous transluminal coronary angioplasty, myocardial adaptation to ischemia was measured using intracoronary (i.c.) electrocardiographic (ECG) ST segment elevation changes obtained from a 0.014-in. (0.036 cm) pressure guidewire positioned distal to the stenosis during three subsequent 2-min balloon occlusions. Simultaneously, an i.c. pressure-derived collateral flow index (CFI, no unit) was determined as the ratio between distal occlusive minus central venous pressure divided by the mean aortic minus central venous pressure. The study patients were divided into two groups according to the pretreatment with i.c. adenosine (2.4 mg/min for 10 min starting 20 min before the first occlusion, n = 15) or with normal saline (control group, n = 15).

Results: Collateral flow index at the first occlusion was not different between the groups (0.15 +/- 0.10 in the adenosine group and 0.13 +/- 0.11 in the control group, p = NS), and it increased significantly and similarly to 0.20 +/- 0.14 and to 0.19 +/- 0.10, respectively (p < 0.01) during the third occlusion. The i.c. ECG ST elevation (normalized for the QRS amplitude) was not different between the two groups at the first occlusion (0.25 +/- 0.13 in the adenosine group, 0.25 +/- 0.19 in the control group). It decreased significantly during subsequent coronary occlusions to 0.20 +/- 0.15 and to 0.17 +/- 0.13, respectively. There was a correlation between the change in CFI (first to third occlusion; deltaCFI) and the respective ST elevation shift (deltaST): deltaST = -0.02 to 0.78 x deltaCFI; r = 0.54, p = 0.02.

Conclusions: Even in patients with few coronary collaterals, the myocardial adaptation to repetitive ischemia is closely related to collateral recruitment. Pharmacologic preconditioning using a treatment with i.c. adenosine before angioplasty does not occur. The variable responses of ECG signs of ischemic adaptation to collateral channel opening suggest that ischemic preconditioning is a relevant factor in the development of ischemic tolerance.

Citing Articles

The Never-ending Story: Assessing coronary collateral circulation with myocardial perfusion imaging.

Sciagra R, Linguanti F J Nucl Cardiol. 2023; 30(6):2346-2348.

PMID: 37291456 DOI: 10.1007/s12350-023-03294-4.


With a Little Help From My Friends: the Role of the Renal Collateral Circulation in Atherosclerotic Renovascular Disease.

Nyvad J, Lerman A, Lerman L Hypertension. 2022; 79(4):717-725.

PMID: 35135307 PMC: 8917080. DOI: 10.1161/HYPERTENSIONAHA.121.17960.


Ischemic Preconditioning and Coronary Collateral Blood Flow Increment: Two Sides of the Same Coin?.

Santillo E, Fallavollita L, Marini L Acta Cardiol Sin. 2019; 35(6):659.

PMID: 31879521 PMC: 6859105. DOI: 10.6515/ACS.201911_35(6).20181101B.


Influence of Cardiovascular Risk Factors, Comorbidities, Medication Use and Procedural Variables on Remote Ischemic Conditioning Efficacy in Patients with ST-Segment Elevation Myocardial Infarction.

Pryds K, Hjortbak M, Schmidt M Int J Mol Sci. 2019; 20(13).

PMID: 31269650 PMC: 6650921. DOI: 10.3390/ijms20133246.


Acute Hemodynamic Effects of Remote Ischemic Preconditioning on Coronary Perfusion Pressure and Coronary Collateral Blood Flow in Coronary Heart Disease.

Xu Y, Yu Q, Yang J, Yuan F, Zhong Y, Zhou Z Acta Cardiol Sin. 2018; 34(4):299-306.

PMID: 30065567 PMC: 6066945. DOI: 10.6515/ACS.201807_34(4).20180317A.